
Design analysis can dictate blister composition

Design analysis can dictate blister composition

Despite a flurry of specialty pharmaceuticals in innovative formats, traditional powder-based dosages will always be a mainstay

Student entries will compete for an award in addition to the commercial contest

Contract development and manufacturing organizations (CDMOs) want to be more reliable business partners to pharma

Viral products, IVIG and stem cell production is coming online

Market-data firm estimates 2020 global drug sales at $987 billion

Heightened concern over adherence and product stability may win over more pharma clients

The Parenteral Drug Association offers risk management guidance*

Persistent drug shortages are mostly attributable to manufacturing quality problems, but the economics of low-margin generic manufacturing challenge the industry

More complex products and higher risk are changing the nature of pharmaceutical outsourcing


The perverse fascination that the business press has with pharma layoffs masks the industry's underlying strength

In the big swing to specialty pharmaceuticals and distribution, some manufacturers are looking for 'good enough' services

Newly branded company is one of the largest contract development and manufacturing organizations (CDMOs) in the world

Fast-tracked product is acclaimed by FDA as well as its developer, Kaléo

Both pharmacological and economic factors drive the decision to use these technologies

Cold chain packagers balance cost, performance and compliance approaches

The trend toward self-administered drugs creates a pressing need for better patient-education resources

Contract packager addresses growing clinical-products business

Analysts find that better adherence can be a competitive advantage in new-product introductions


Advanced label technologies serve functions far beyond product identification

The size of clinical trials continues to expand, observers say, creating a ripple effect in pharmaceutical packaging.

Vaccine administration is shifting from multidose vials to prefilled syringes for a host of important safety and economic considerations

Besides the ongoing debate over serialization, drug labels are playing a greater role in anti-counterfeiting, preventing medication errors and improving patient adherence